| Combination of | |
|---|---|
| Sitagliptin | Dipeptidyl peptidase-4 inhibitor |
| Metformin | Biguanide |
| Clinical data | |
| Pregnancy cat. | B(US) |
| Legal status | ℞-only (US) |
| Routes | Oral |
| Identifiers | |
| ATC code | A10BD07 |
Sitagliptin/metformin (trade name Janumet) is an anti-diabetic drug, being a combination drug of sitagliptin (a dipeptidyl peptidase-4 inhibitor) and metformin.